Study: Pfizer Covid-19 Booster Vaccine Provide Strong Immune Response in 5 to 11 Years Kids


According to new study from Pfizer and BioNTech, the healthy children aged between 5 to 11 years old kids are getting strong immune response from the novel corona virus vaccine developed by Pfizer and BioNTech.

The blood samples from the 30 children, who has now received a third shot of the corona virus vaccine has showed a 36-fold increase in the antibodies against the omicron covid-19 variant of the corona virus and in around 140 children, a third dose has increased the antibodies sixfold against the original strain of the corona virus.

Because, the novel corona virus vaccine has approved for the adults and the medicine regulators has allowed the immune response for being used as a metric of effectiveness instead of the actual infections and no new safety issues has been arose among the 400 children in the covid-19 booster vaccine trial.

According to a new release of Pfizer, the positive results has also reinforced the potential function of a third dose of the corona virus vaccine in maintaining the high levels of the protection against the corona virus in the particular age group.

See also  Cannabis Oil: Can It Be Used As Medicine?

Both the companies have been planning shortly for asking the Food and Drug Administration (FDA) of the United States for the purpose of authorizing the booster covid-19 vaccine shots for the children aged between 5 to 11 years old.